Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$21.8M Sell
60,172
-34,536
-36% -$11.8M 0.23% 71
2026
Q1
$33.3M Buy
94,708
+35,295
+59% +$12.6M 0.34% 44
2025
Q4
$19.4M Buy
59,413
+926
+2% +$294K 0.23% 78
2025
Q3
$16.5M Buy
58,487
+1,141
+2% +$331K 0.21% 83
2025
Q2
$16M Buy
57,346
+720
+1% +$204K 0.23% 78
2025
Q1
$17.6M Buy
+56,626
New +$16.7M 0.29% 64

Other funds holding AMGN

OP Asset Management's AMGN Position: Q2 2026 in Review

OP Asset Management reduced its Amgen (AMGN) stake by 36% in Q2 2026, selling an estimated $11.8M and leaving 60,172 shares worth $21.8M. The position accounts for 0.23% of the portfolio, ranked #71.

OP Asset Management first reported a position in AMGN in Q1 2025 and has held it in 6 quarters since. The position peaked at $33.3M in Q1 2026. 1,262 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • OP Asset Management held 60,172 shares of Amgen worth $21.8M as of Q2 2026.
  • OP Asset Management sold 34,536 Amgen shares in Q2 2026, an estimated $11.8M.
  • Amgen made up 0.23% of OP Asset Management's portfolio in Q2 2026, its #71 holding.
  • OP Asset Management first reported a position in Amgen in Q1 2025 and has held it in 6 quarters since.
  • OP Asset Management's Amgen position peaked at $33.3M in Q1 2026.
  • 1,262 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on OP Asset Management's 13F filing for Q2 2026, filed 28 Jul 2026.